Free Republic

New technologies such as 3D bioprinting promise to offer a laundry list of new treatments, drug discovery, and cures within the medical industry. With that said, we have been hearing promises for years that 3D printing will change the face of medicine. Despite these promises, bioprinting has yet to make any major impact within the market. Today things may have just changed! San Diego-based 3D bioprinting company Organovo (NYSE MKT: ONVO) has today announced the full commercial availability of their exVive3D Human Liver Tissue for preclinical drug discovery testing. The tissue, which is created via an in-house 3D printer, could...

At the Inside 3D Printing conference in Chicago this week, Microsoft senior program manager Jesse McGatha provided a little context on the company’s June announcement that Windows 8.1 will support 3D printing. But while Microsoft says it wants to help eradicate the barriers to adoption for consumers, it’s really just setting itself up to capture the market if and when somebody else does. Microsoft’s initial announcement in late June explained that Windows 8.1 will provide plug-and-play support for 3D printers, the ability to read different file formats, and support for third-party apps that manage the printers. But at the conference,...